SC 13G Filing

Company

ROCKET PHARMACEUTICALS, INC.

Filed

January 3, 2017

Accession Number

0000930413-17-000013

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →